Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 10:01 PM
Study NCT ID:
NCT04610658
Status:
TERMINATED
Last Update Posted:
2024-04-02
First Post:
2020-10-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-23
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-24
Completion Date Type:
ACTUAL
First Submit Date:
2020-10-26
First Submit QC Date:
None
Study First Post Date:
2020-10-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-01
Last Update Post Date:
2024-04-02
Last Update Post Date Type:
ACTUAL